Language:

Cost-Effectiveness of Universal or High-Risk Screening Compared to Surveillance Monitoring in Autism Spectrum Disorder

Journal of autism and developmental disorders, 2018-09, Vol.48 (9), p.2968-2979 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Journal of Autism and Developmental Disorders is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0162-3257 ;EISSN: 1573-3432 ;DOI: 10.1007/s10803-018-3571-4 ;PMID: 29644584

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Cost-Effectiveness of Universal or High-Risk Screening Compared to Surveillance Monitoring in Autism Spectrum Disorder
Author: Yuen, Tracy ; Carter, Melissa T. ; Szatmari, Peter ; Ungar, Wendy J.
Subjects: At Risk Persons ; Autism ; Autism Spectrum Disorder - diagnosis ; Autism Spectrum Disorder - economics ; Autism Spectrum Disorder - epidemiology ; Autistic children ; Behavioral Science and Psychology ; Care and treatment ; Child ; Child and School Psychology ; Child, Preschool ; Childbirth & labor ; Children ; Clinical Diagnosis ; Comparative Analysis ; Cost analysis ; Cost benefit analysis ; Cost control ; Cost Effectiveness ; Cost-Benefit Analysis - methods ; Diagnosis ; Economic aspects ; Female ; Health screening ; High risk ; Humans ; Infant ; Male ; Mass Screening - economics ; Mass Screening - methods ; Medical screening ; Neurosciences ; Original Paper ; Patient outcomes ; Pediatrics ; Pervasive Developmental Disorders ; Psychology ; Public Health ; Risk Factors ; Savings ; Screening Tests ; Simulation ; Surveillance ; United States - epidemiology ; Waiting times ; Young Children
Is Part Of: Journal of autism and developmental disorders, 2018-09, Vol.48 (9), p.2968-2979
Description: The American Academy of Pediatrics recommends universal screening for autism spectrum disorder at 18 and 24 months. This study compared the cost-effectiveness of universal or high-risk screening to surveillance monitoring. Simulation models estimated the costs and outcomes from birth to age 6 years. The incremental cost per child diagnosed by 36 months was $41,651.6 for high-risk screening and $757,116.9 for universal screening from the societal perspective. Universal screening may not be a cost-effective approach to increase earlier treatment initiation, as most children initiated treatment after age 60 months. Eliminating wait times resulted in more children initiated treatment by 48 months, but at a high initial cost that may be offset by future cost-savings related to better outcomes.
Publisher: New York: Springer US
Language: English
Identifier: ISSN: 0162-3257
EISSN: 1573-3432
DOI: 10.1007/s10803-018-3571-4
PMID: 29644584
Source: ProQuest One Psychology
Education Resources Information Center (ERIC)
AUTh Library subscriptions: ProQuest Central
MEDLINE

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Cost-Effectiveness of Universal or High-Risk Screening Compared to Surveillance Monitoring in Autism Spectrum Disorder

Springer Science+Business Media, LLC, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Journal of Autism and Developmental Disorders is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0162-3257 ;EISSN: 1573-3432 ;DOI: 10.1007/s10803-018-3571-4 ;PMID: 29644584

Searching Remote Databases, Please Wait